Haplotype analyses of cholesteryl ester transfer protein gene promoter

A clue to an unsolved mystery of TaqIB polymorphism

Hong Lu, Akihiro Inazu, Yuri Moriyama, Toshinori Higashikata, Masa Aki Kawashiri, Wenxin Yu, Zhiping Huang, Tomonori Okamura, Hiroshi Mabuchi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins. TaqIB polymorphism (B2 allele) identified in intron 1 is associated with lower plasma CETP concentrations and higher HDL cholesterol levels and may play an antiatherogenic role in humans, However, its molecular mechanism remains unclear. To evaluate the association between the promoter polymorphisms and CETP/HDL cholesterol levels, ten novel and three previously reported polymorphisms located within 3.3 kb of the CETP gene promoter were investigated in a sample of 357 elderly Japanese men. All the promoter polymorphisms were in linkage disequilibrium with each other and with TaqIB. The -2505A allele, the "S" allele of the [gaaa]n repeat ("S" denotes [gaaa]n=329 bp and longer, "L" denotes >329 bp) and TaqIB2 allele were significantly associated with both lower plasma CETP concentrations and higher HDL cholesterol levels whereas -971G/A and -629A/C were significantly associated with CETP concentrations but not with HDL-C levels. The 12-polymorphism haplotypes consisting of -2804, -2505, [gaaa]n, -1930, -1674, -1129, -1046, -971, -875, -827, -629, and TaqIB were analyzed. These 12 polymorphisms generated eight main haplotypes, accounting for 86% of the observed haplotypes. The G/A/S/T/T/C/T/A/C/C/A/B2 haplotype was significantly associated with lower CETP concentrations (2.0±0.6 μg/ml) and higher HDL cholesterol levels (55.1±12.7 mg/dl) than the other seven main haplotypes. The 5- and 3-polymorphism haplotype analyses consisting of -2505 and the [gaaa]n repeat indicated the -2505C/A polymorphism might explain the variation in the CETP concentrations best, and the [gaaa]n repeat and/or the -2505C/A polymorphism may independently determine the variation in HDL cholesterol levels, whereas the -629A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations as well as HDL cholesterol levels, although the latter has been frequently examined in many association studies.

Original languageEnglish
Pages (from-to)246-255
Number of pages10
JournalJournal of Molecular Medicine
Volume81
Issue number4
Publication statusPublished - 2003 Apr 1
Externally publishedYes

Fingerprint

Cholesterol Ester Transfer Proteins
Haplotypes
HDL Cholesterol
Genes
Hypercholesterolemia
Alleles
Blood Proteins
Linkage Disequilibrium
Introns
Lipoproteins
Triglycerides

Keywords

  • Cholesteryl ester transfer protein
  • High-density lipoprotein cholesterol
  • Polymorphisms
  • Promoter
  • TaqIB

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lu, H., Inazu, A., Moriyama, Y., Higashikata, T., Kawashiri, M. A., Yu, W., ... Mabuchi, H. (2003). Haplotype analyses of cholesteryl ester transfer protein gene promoter: A clue to an unsolved mystery of TaqIB polymorphism. Journal of Molecular Medicine, 81(4), 246-255.

Haplotype analyses of cholesteryl ester transfer protein gene promoter : A clue to an unsolved mystery of TaqIB polymorphism. / Lu, Hong; Inazu, Akihiro; Moriyama, Yuri; Higashikata, Toshinori; Kawashiri, Masa Aki; Yu, Wenxin; Huang, Zhiping; Okamura, Tomonori; Mabuchi, Hiroshi.

In: Journal of Molecular Medicine, Vol. 81, No. 4, 01.04.2003, p. 246-255.

Research output: Contribution to journalArticle

Lu, H, Inazu, A, Moriyama, Y, Higashikata, T, Kawashiri, MA, Yu, W, Huang, Z, Okamura, T & Mabuchi, H 2003, 'Haplotype analyses of cholesteryl ester transfer protein gene promoter: A clue to an unsolved mystery of TaqIB polymorphism', Journal of Molecular Medicine, vol. 81, no. 4, pp. 246-255.
Lu, Hong ; Inazu, Akihiro ; Moriyama, Yuri ; Higashikata, Toshinori ; Kawashiri, Masa Aki ; Yu, Wenxin ; Huang, Zhiping ; Okamura, Tomonori ; Mabuchi, Hiroshi. / Haplotype analyses of cholesteryl ester transfer protein gene promoter : A clue to an unsolved mystery of TaqIB polymorphism. In: Journal of Molecular Medicine. 2003 ; Vol. 81, No. 4. pp. 246-255.
@article{c1787adde7ef405c8aea78c9ec9acc8f,
title = "Haplotype analyses of cholesteryl ester transfer protein gene promoter: A clue to an unsolved mystery of TaqIB polymorphism",
abstract = "Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins. TaqIB polymorphism (B2 allele) identified in intron 1 is associated with lower plasma CETP concentrations and higher HDL cholesterol levels and may play an antiatherogenic role in humans, However, its molecular mechanism remains unclear. To evaluate the association between the promoter polymorphisms and CETP/HDL cholesterol levels, ten novel and three previously reported polymorphisms located within 3.3 kb of the CETP gene promoter were investigated in a sample of 357 elderly Japanese men. All the promoter polymorphisms were in linkage disequilibrium with each other and with TaqIB. The -2505A allele, the {"}S{"} allele of the [gaaa]n repeat ({"}S{"} denotes [gaaa]n=329 bp and longer, {"}L{"} denotes >329 bp) and TaqIB2 allele were significantly associated with both lower plasma CETP concentrations and higher HDL cholesterol levels whereas -971G/A and -629A/C were significantly associated with CETP concentrations but not with HDL-C levels. The 12-polymorphism haplotypes consisting of -2804, -2505, [gaaa]n, -1930, -1674, -1129, -1046, -971, -875, -827, -629, and TaqIB were analyzed. These 12 polymorphisms generated eight main haplotypes, accounting for 86{\%} of the observed haplotypes. The G/A/S/T/T/C/T/A/C/C/A/B2 haplotype was significantly associated with lower CETP concentrations (2.0±0.6 μg/ml) and higher HDL cholesterol levels (55.1±12.7 mg/dl) than the other seven main haplotypes. The 5- and 3-polymorphism haplotype analyses consisting of -2505 and the [gaaa]n repeat indicated the -2505C/A polymorphism might explain the variation in the CETP concentrations best, and the [gaaa]n repeat and/or the -2505C/A polymorphism may independently determine the variation in HDL cholesterol levels, whereas the -629A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations as well as HDL cholesterol levels, although the latter has been frequently examined in many association studies.",
keywords = "Cholesteryl ester transfer protein, High-density lipoprotein cholesterol, Polymorphisms, Promoter, TaqIB",
author = "Hong Lu and Akihiro Inazu and Yuri Moriyama and Toshinori Higashikata and Kawashiri, {Masa Aki} and Wenxin Yu and Zhiping Huang and Tomonori Okamura and Hiroshi Mabuchi",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "81",
pages = "246--255",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Haplotype analyses of cholesteryl ester transfer protein gene promoter

T2 - A clue to an unsolved mystery of TaqIB polymorphism

AU - Lu, Hong

AU - Inazu, Akihiro

AU - Moriyama, Yuri

AU - Higashikata, Toshinori

AU - Kawashiri, Masa Aki

AU - Yu, Wenxin

AU - Huang, Zhiping

AU - Okamura, Tomonori

AU - Mabuchi, Hiroshi

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins. TaqIB polymorphism (B2 allele) identified in intron 1 is associated with lower plasma CETP concentrations and higher HDL cholesterol levels and may play an antiatherogenic role in humans, However, its molecular mechanism remains unclear. To evaluate the association between the promoter polymorphisms and CETP/HDL cholesterol levels, ten novel and three previously reported polymorphisms located within 3.3 kb of the CETP gene promoter were investigated in a sample of 357 elderly Japanese men. All the promoter polymorphisms were in linkage disequilibrium with each other and with TaqIB. The -2505A allele, the "S" allele of the [gaaa]n repeat ("S" denotes [gaaa]n=329 bp and longer, "L" denotes >329 bp) and TaqIB2 allele were significantly associated with both lower plasma CETP concentrations and higher HDL cholesterol levels whereas -971G/A and -629A/C were significantly associated with CETP concentrations but not with HDL-C levels. The 12-polymorphism haplotypes consisting of -2804, -2505, [gaaa]n, -1930, -1674, -1129, -1046, -971, -875, -827, -629, and TaqIB were analyzed. These 12 polymorphisms generated eight main haplotypes, accounting for 86% of the observed haplotypes. The G/A/S/T/T/C/T/A/C/C/A/B2 haplotype was significantly associated with lower CETP concentrations (2.0±0.6 μg/ml) and higher HDL cholesterol levels (55.1±12.7 mg/dl) than the other seven main haplotypes. The 5- and 3-polymorphism haplotype analyses consisting of -2505 and the [gaaa]n repeat indicated the -2505C/A polymorphism might explain the variation in the CETP concentrations best, and the [gaaa]n repeat and/or the -2505C/A polymorphism may independently determine the variation in HDL cholesterol levels, whereas the -629A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations as well as HDL cholesterol levels, although the latter has been frequently examined in many association studies.

AB - Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to triglyceride-rich lipoproteins. TaqIB polymorphism (B2 allele) identified in intron 1 is associated with lower plasma CETP concentrations and higher HDL cholesterol levels and may play an antiatherogenic role in humans, However, its molecular mechanism remains unclear. To evaluate the association between the promoter polymorphisms and CETP/HDL cholesterol levels, ten novel and three previously reported polymorphisms located within 3.3 kb of the CETP gene promoter were investigated in a sample of 357 elderly Japanese men. All the promoter polymorphisms were in linkage disequilibrium with each other and with TaqIB. The -2505A allele, the "S" allele of the [gaaa]n repeat ("S" denotes [gaaa]n=329 bp and longer, "L" denotes >329 bp) and TaqIB2 allele were significantly associated with both lower plasma CETP concentrations and higher HDL cholesterol levels whereas -971G/A and -629A/C were significantly associated with CETP concentrations but not with HDL-C levels. The 12-polymorphism haplotypes consisting of -2804, -2505, [gaaa]n, -1930, -1674, -1129, -1046, -971, -875, -827, -629, and TaqIB were analyzed. These 12 polymorphisms generated eight main haplotypes, accounting for 86% of the observed haplotypes. The G/A/S/T/T/C/T/A/C/C/A/B2 haplotype was significantly associated with lower CETP concentrations (2.0±0.6 μg/ml) and higher HDL cholesterol levels (55.1±12.7 mg/dl) than the other seven main haplotypes. The 5- and 3-polymorphism haplotype analyses consisting of -2505 and the [gaaa]n repeat indicated the -2505C/A polymorphism might explain the variation in the CETP concentrations best, and the [gaaa]n repeat and/or the -2505C/A polymorphism may independently determine the variation in HDL cholesterol levels, whereas the -629A/C and TaqIB polymorphisms were not instrumental in determining CETP concentrations as well as HDL cholesterol levels, although the latter has been frequently examined in many association studies.

KW - Cholesteryl ester transfer protein

KW - High-density lipoprotein cholesterol

KW - Polymorphisms

KW - Promoter

KW - TaqIB

UR - http://www.scopus.com/inward/record.url?scp=0038245111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038245111&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 246

EP - 255

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 4

ER -